SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (943)3/30/2006 11:41:27 PM
From: Mike McFarlandRead Replies (1) | Respond to of 1336
 
LION Tripos ACCL
just under the general heading of consolidation,
preliminary surfing, don't know much about LION

Many European companies have scrapped U.S. listings in the wake of the Act, including British biotech firm Provalis (PRO.L: Quote, Profile, Research) and Germany's Lion Bioscience (LIOG.DE: Quote, Profile, Research), saving around $1 million a year in costs.

Message 22196396

Message 20779470

bio-itworld.com



To: Mike McFarland who wrote (943)3/31/2006 12:13:56 AM
From: zeta1961Respond to of 1336
 
How interesting that PCOP has a following over here..bought them during the nano-bubble[however short lived!]and sold them post the split..their work too complicated to make even a quasi intelligent assessment..what are they up to?

edit: ouch!..still trigger regret..

edit2: up 20% today..another ouchie for the still trigger

Elisabeth


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News